Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

CBD boosts Anti-Craving drug in alcohol addiction trial

NCT ID NCT06845124

First seen Feb 03, 2026 · Last updated May 25, 2026 · Updated 16 times

Summary

This study tests whether adding cannabidiol (CBD) to the standard medication naltrexone can better reduce alcohol cravings in people with alcohol addiction. About 150 adults who experience strong cravings will receive either a high dose of CBD plus naltrexone, a lower dose of CBD plus naltrexone, or a placebo plus naltrexone for 14 days. The goal is to see if the combination helps control cravings more effectively than naltrexone alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOLISM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Central Institute of Mental Health

    RECRUITING

    Mannheim, 68159, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Psychiatric Centre North Baden (PZN)

    NOT_YET_RECRUITING

    Wiesloch, Baden-Wurttemberg, 69168, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.